Document is current
Any future updates will be listed below
-
Authors
Vollherbst, Dominik F. https://orcid.org/0000-0002-8992-4757
Berlis, Ansgar
Zaki, Mahmoud
Maurer, Christoph
Onyinzo, Christina
Keil, Fee C.
Mann, Leonard
Arendt, Christophe T.
Hartmann, Marius
Reißberg, Steffen
Rutschke, Corinna
Kallenberg, Kai
Grau, Stefan
Durutya, Alexandru
Liebert, Adrian
Voit-Höhne, Heinz L.
Holtmannspötter, Markus
Herweh, Christian
Chapot, René
Elsharkawy, Mohamed
Meila, Dan
Greling, Björn
Boxberg, Frederik
Grieb, Dominik
Deuschl, Cornelius
Ahmadipour, Yahya
Boeckh-Behrens, Tobias
Bodden, Jannis
Lukas, Carsten
Kämmerer, Felix
Behme, Daniel
Diamandis, Elie
Siebert, Eberhard
Meddeb, Aymen
Kreiser, Kornelia
Heinz, Sabine
Meckel, Stephan
Berzeg-Kolck, Semin
Fiehler, Jens
Bechstein, Matthias
Kaschner, Marius G.
Darvishi, Keihan
Leukert, Laura S.
Brockmann, Marc A.
Mayer, Thomas E.
Buhk, Jan-Hendrik
Weyland, Charlotte S.
Görtz, Lukas
Kabbasch, Christoph
Weber, Werner
Wendl, Christina
Struffert, Tobias
Dyzmann, Christian
Gerber, Johannes C.
Bendszus, Martin
Möhlenbruch, Markus A.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 28 April 2025
Accepted: 12 July 2025
First Online: 18 August 2025
Conflict of interest
: D.F. Vollherbst reports consultancy for Medtronic Neurovascular, and Paid Lectures for Cerenovus, TerumoNeuro and Balt. T. Boeck-Behrens reports consultancy for Terumo Neuro, BALT, MIVI and Acandis and received speaker fees from Philips. C. Lukas received consulting and speaker’s honoraria from Biogen Idec, Bayer Vital GmbH, BMS, Daiichi Sankyo, Merck Serono, Novartis and Sanofi. F. Kämmerer received consulting honoraria and travel grants from Cerenovous & travel grants from Balt and wallabyphenox. S. Meckel reports consultancy for Acandis GmbH, Balt, Medtronic and Stryker, and paid lectures for Penumbra, and is Member of the Scientific Advisory Board for Novartis Pharma GmbH. C. Kabbasch serves as consultant for Acandis GmbH (Pforzheim, Germany) and as proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA). MB reports board membership: DSMB Vascular Dynamics; consultancy: Roche, Guerbet, Codman; grants/grants pending: DFG, Hopp Foundation, Novartis, Siemens, Guerbet, Stryker, Covidien; payment for lectures (including service on speakers bureaus): Novartis, Roche, Guerbet, Teva, Bayer, Codman. MAM has received consulting honoraria, speaker honoraria, and travel support outside this work from Codman, Covidien/Medtronic, MicroVention, Phenox, and Stryker. The other authors declare that they do not have any conflicts of interest.
